Walleye Capital
RETA

Walleye Capital’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Walleye Capital’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$196K Sell
2023
Q1 		$1.28M Buy
2022
Q4 		– Sell
2022
Q3 		$513K Buy
2022
Q1 		– Sell
2021
Q4 		$1.35M Buy
2019
Q4 		– Sell
2019
Q3 		$622K Buy